您的位置: 首页 > 农业专利 > 详情页

ANTIBODIES AGAINST TL1A AND USES THEREOF
专利权人:
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
发明人:
POULTON LYNN DOROTHY,CLARKE ADAM,POW ANDREW JAMES,TAMVAKIS DEBRA,KOPSIDAS GEORGE,DOYLE ANTHONY GERARD,JENNINGS PHILIP ANTHONY,POLLARD MATTHEW
申请号:
ZA201401843
公开号:
ZA201401843B
申请日:
2014.03.13
申请国别(地区):
ZA
年份:
2015
代理人:
摘要:
The present disclosure provides TNF-like ligand 1a (TL1a)-binding proteins comprising an antigen binding domain of an antibody which binds specifically to TL1a and inhibits interaction of TL1a and Death Receptor 3 (DR3) and which does not inhibit the interaction of TL1a and Decoy Receptor 3 (DcR3). The present disclosure also provides uses of the TL1a-binding proteins.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充